awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36929947-9E5F7278-192D-4B36-B038-B0F07E64C79F
Q36929947-9E5F7278-192D-4B36-B038-B0F07E64C79F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36929947-9E5F7278-192D-4B36-B038-B0F07E64C79F
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.
P2860
Q36929947-9E5F7278-192D-4B36-B038-B0F07E64C79F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36929947-9E5F7278-192D-4B36-B038-B0F07E64C79F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4d941b1475bceba32f4c9c7459cd6d184c01c14
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.